News
& Press
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced
Lexaria Announces Pricing of $1.6 Million Registered Direct Offering
Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms,
Safe & Green Holdings Corp. Completes Spin-Off of Safe and Green Development Corporation
Safe & Green Holdings Corp. (NASDAQ: SGBX) (“SG Holdings” or the “Company”), a leading developer,
Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement
Ainos, Inc. (NASDAQ: AIMD, AIMDW) (“Ainos”, or the “Company”), a diversified healthcare company focused on
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “Company”), a global leader in dental lasers, today announced the pricing
SIMPPLE LTD. Announces Pricing of US$8.4 Million Initial Public Offering
SIMPPLE LTD. (the “Company” or “SIMPPLE”), an advanced technology solution provider in the emerging property-technology
Edible Garden Announces Pricing of $3.0 Million Underwritten Public Offering
Edible Garden AG Incorporated (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally
Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced the pricing of its public
Imperial Petroleum Inc. Announces Pricing of Approximately $17.0 Million Registered Direct Offering
IMPERIAL PETROLEUM INC. (NASDAQ: IMPP, the “Company”), a ship-owning company providing petroleum products, crude oil
Nxu Inc. Announces $5 Million Public Offering
Nxu Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a vertically integrated technology company creating energy storage
Tivic Health Announces Pricing of $1.4 Million Public Offering of Common Stock
Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and
INVO Bioscience Announces Pricing of $4.5 Million Public Offering
INVO Bioscience, Inc. (Nasdaq:INVO), a healthcare services fertility company focused on expanding access to advanced
SuperCom Announces Pricing of $2.75 Million Public Offering
SuperCom (NASDAQ: SPCB) (“SuperCom” or the “Company”), a global provider of secured solutions for the e-Government,
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the pricing of its public
Cheetah Net Supply Chain Service Inc. Announces Pricing of $5.0 Million Initial Public Offering
Cheetah Net Supply Chain Service Inc. (NASDAQ: CTNT), a supplier of parallel-import vehicles sourced in
Contango ORE Announces Pricing of $30.4 Million Underwritten Public Offering of Common Stock
Contango ORE, Inc. (“Contango,” “CORE” or the “Company”) (NYSE American: CTGO), today announced the pricing
FangDD Announces US$8.0 Million Registered Direct Offering
Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”), a customer-oriented PropTech company in
Tivic Health Announces Pricing of $2.1 Million Public Offering of Common Stock
Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes
PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement
PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics,
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver,
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic,
SEALSQ Announces Closing of an Initial $10.0 Million Tranche of a Private Placement of Convertible Notes and Warrants
SEALSQ Corp (Nasdaq: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty pharmaceutical company focused on the reformulation
Siyata Mobile Inc. Announces Pricing of Approximately $2.3 Million Registered Direct Offering
Siyata Mobile Inc. (NASDAQ:SYTA)(NASDAQ:SYTAW) (“Siyata” or the “Company”), a global vendor of Push-to-Talk over Cellular